AMD3100-mediated CXCR4 inhibition impairs development of primary lymphoma of the central nervous system. Montesinos-Rongen M, Sanchez-Ruiz M, Siebert S, Winter C, et al. Am J Pathol 2023 May 15:S0002-9440(23)00163.

Read + Share

Amedeo Smart

Independent Medical Education

Montesinos-Rongen M, Sanchez-Ruiz M, Siebert S, Winter C, et al. AMD3100-mediated CXCR4 inhibition impairs development of primary lymphoma of the central nervous system. Am J Pathol 2023 May 15:S0002-9440(23)00163.
PMID: 37196929